Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which focuses on the treatment of spinal cord injuries. Its treatment approach is the Neuro-Spinal Scaffold implant, which is designed for implantation at the site of injury within a spinal cord and is intended to treat acute SCI. The company was founded by Joseph P. Vacanti, Frank M. Reynolds and Robert Langer on November 28, 2005 and is headquartered in Cambridge, MA.